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Previous work by Garcia Ponce et al. and Citalán-Madrid et al. suggesting a link between cortactin and RhoA-mediated actomyosin contractility was inadvertently omitted from the original version of this manuscript and should have been cited within the "Discussion" section as follows:

"Previous studies in cortactin-null endothelium and intestinal epithelium revealed hyperactivated RhoA-mediated contractility in these cell types, contrasting with the decrease in junctional RhoA signaling and contractility that we observed, but the direct involvement of cortactin in mediating actomyosin contractility was not established^1,2^. Future research will have to explore the compatibility of these observations."
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